ZA200709269B - Protein kinase inhibitors - Google Patents

Protein kinase inhibitors

Info

Publication number
ZA200709269B
ZA200709269B ZA200709269A ZA200709269A ZA200709269B ZA 200709269 B ZA200709269 B ZA 200709269B ZA 200709269 A ZA200709269 A ZA 200709269A ZA 200709269 A ZA200709269 A ZA 200709269A ZA 200709269 B ZA200709269 B ZA 200709269B
Authority
ZA
South Africa
Prior art keywords
protein kinase
kinase inhibitors
inhibitors
protein
kinase
Prior art date
Application number
ZA200709269A
Other languages
English (en)
Inventor
David J Bearss
Vankayalapati Hariprasad
Cory L Grand
Original Assignee
Supergen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Supergen Inc filed Critical Supergen Inc
Publication of ZA200709269B publication Critical patent/ZA200709269B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Transplantation (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA200709269A 2005-04-28 2007-10-26 Protein kinase inhibitors ZA200709269B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US67646705P 2005-04-28 2005-04-28

Publications (1)

Publication Number Publication Date
ZA200709269B true ZA200709269B (en) 2009-01-28

Family

ID=37029567

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200709269A ZA200709269B (en) 2005-04-28 2007-10-26 Protein kinase inhibitors

Country Status (13)

Country Link
US (1) US20090029982A1 (fr)
EP (1) EP1888588A2 (fr)
JP (1) JP2008539277A (fr)
KR (1) KR20080020602A (fr)
CN (1) CN101189239A (fr)
AU (1) AU2006239236A1 (fr)
BR (1) BRPI0609956A2 (fr)
CA (1) CA2604284A1 (fr)
IL (1) IL186744A0 (fr)
MX (1) MX2007013624A (fr)
NO (1) NO20075113L (fr)
WO (1) WO2006116733A2 (fr)
ZA (1) ZA200709269B (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2621261C (fr) 2005-09-22 2014-05-20 Incyte Corporation Inhibiteurs tetracycliques de janus kinases
ES2415863T3 (es) 2006-12-22 2013-07-29 Incyte Corporation Heterociclos sustituidos como inhibidores de Janus Quinasas
CA2682733A1 (fr) * 2007-04-13 2008-10-23 Supergen, Inc. Inhibiteurs de la kinase axl
US8618121B2 (en) 2007-07-02 2013-12-31 Cancer Research Technology Limited 9H-pyrimido[4,5-B]indoles, 9H-pyrido[4',3':4,5]pyrrolo[2,3-D]pyridines, and 9H 1,3,6,9 tetraaza-fluorenes as CHK1 kinase function inhibitors
ES2551352T3 (es) * 2007-07-05 2015-11-18 Array Biopharma, Inc. Pirimido ciclopentanos útiles para el tratamiento de enfermedades inflamatorias o hiperproliferativas
FR2933983B1 (fr) * 2008-07-15 2010-08-27 Servier Lab Nouveaux derives tricycliques,leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US10699235B2 (en) * 2009-05-05 2020-06-30 Oracle America, Inc. System, method and computer readable medium for placing advertisements into web pages
MX345780B (es) 2011-03-15 2017-02-15 Trius Therapeutics Inc Inhibidores triciclicos de girasa.
ES2671748T3 (es) 2011-07-21 2018-06-08 Tolero Pharmaceuticals, Inc. Inhibidores heterocíclicos de proteína quinasas
RU2641693C2 (ru) 2011-11-09 2018-01-22 Кансер Ресёрч Текнолоджи Лимитед Соединения 5-(пиридин-2-иламино)-пиразин-2-карбонитрила и их терапевтическое применение
SG11201404241SA (en) * 2012-01-27 2014-08-28 Univ Montreal Pyrimido[4,5-b]indole derivatives and use thereof in the expansion of hematopoietic stem cells
RU2659786C2 (ru) 2012-05-15 2018-07-04 Кансер Ресёрч Текнолоджи Лимитед 5-[[4-[[морфолин-2-ил]метиламино]-5-(трифторметил)-2-пиридил]амино]пиразин-2-карбонитрил, его терапевтические применения
CN104804002B (zh) * 2015-04-08 2017-02-01 河南师范大学 一种9H‑嘧啶并[4,5‑b]吲哚类化合物的合成方法
JP6954844B2 (ja) 2015-06-05 2021-10-27 エマ−ケベック 造血幹細胞を培養するため及び／又は造血幹細胞を前駆体へ分化させるための方法及びその使用
CN105037374B (zh) * 2015-07-14 2017-04-12 吉林大学 N‑丁基‑9H‑嘧啶并[4,5‑b]吲哚‑2‑甲酰胺的制备方法
EP3464566A4 (fr) 2016-06-01 2020-01-08 Universite De Montreal Sélection de cellules souches hématopoïétiques humaines à l'aide de l'epcr
WO2019161494A1 (fr) 2018-02-20 2019-08-29 Universite De Montreal Expansion de cellules nk et dc in vivo médiant une réponse immunitaire
BR112020020246A8 (pt) 2018-04-05 2022-10-18 Sumitomo Dainippon Pharma Oncology Inc Inibidores de cinase axl e uso dos mesmos
CA3127502A1 (fr) 2019-02-12 2020-08-20 Sumitomo Dainippon Pharma Oncology, Inc. Formulations comprenant des inhibiteurs de proteine kinase heterocycliques
CA3164153A1 (fr) * 2019-12-18 2021-06-24 Universite De Montreal Modulateurs de l'adaptateur de cullin 3 kbtbd4 en tant que composes anticancereux

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU719392B2 (en) * 1996-10-01 2000-05-11 Kyowa Hakko Kirin Co., Ltd. Nitrogen-containing heterocyclic compounds
RU2002110461A (ru) * 1999-09-21 2004-03-10 Астразенека Аб (Se) Производные хиназолина и их применение в качестве фармацевтических веществ
CA2426440C (fr) * 2000-08-18 2011-03-15 Millennium Pharmaceuticals, Inc. Derives de quinazoline utilises comme inhibiteurs de kinase
AU2002336462A1 (en) * 2001-09-06 2003-03-24 Millennium Pharmaceuticals, Inc. Piperazine and homopiperazine compounds
WO2003037898A1 (fr) * 2001-10-31 2003-05-08 Bayer Healthcare Ag Derives de pyrimido [4,5-b] indole
GB0313766D0 (en) * 2003-06-13 2003-07-23 Xenova Ltd Pharmaceutical compounds
PT1678166E (pt) * 2003-10-14 2009-10-30 Supergen Inc Inibidores de proteína-quinase

Also Published As

Publication number Publication date
WO2006116733A2 (fr) 2006-11-02
NO20075113L (no) 2007-11-23
JP2008539277A (ja) 2008-11-13
AU2006239236A1 (en) 2006-11-02
US20090029982A1 (en) 2009-01-29
CA2604284A1 (fr) 2006-11-02
WO2006116733A3 (fr) 2006-12-14
IL186744A0 (en) 2008-02-09
CN101189239A (zh) 2008-05-28
KR20080020602A (ko) 2008-03-05
MX2007013624A (es) 2008-02-12
EP1888588A2 (fr) 2008-02-20
BRPI0609956A2 (pt) 2010-05-18

Similar Documents

Publication Publication Date Title
ZA200709269B (en) Protein kinase inhibitors
IL191294A0 (en) Imidazopyrazines as protein kinase inhibitors
IL190078A0 (en) Kinase inhibitors
IL190598A0 (en) Pyrazolopyrimidines as protein kinase inhibitors
HK1114380A1 (en) Pyrrolopyrazoles as kinase inhibitors
PL1874770T3 (pl) Fenyloacetamidy odpowiednie jako inhibitory kinaz białkowych
EP1794137A4 (fr) Inhibiteurs de kinases specifiques
ZA200606683B (en) Pyrazolotriazines as kinase inhibitors
IL198487A0 (en) 2-aminothiazole-4-carboxylic amides as protein kinase inhibitors
IL186526A0 (en) Substituted amide derivatives as protein kinase inhibitors
HK1105415A1 (en) Pyrazole-substituted aminoheteroaryl compounds as protein kinase inhibitors
PL1943243T3 (pl) Inhibitory kinazy
EP1968950A4 (fr) Inhibiteurs de pyrimidine kinase
IL206416A0 (en) Benzofuropyrimidinones as protein kinase inhibitors
IL198398A0 (en) 2-aminothiazole-4-carboxylic amides as protein kinase inhibitors
IL183276A0 (en) Kinase inhibitors
HK1100141A1 (en) Kinase inhibitors
EP1912639A4 (fr) Inhibiteurs de la thiazolopyrimidine kinase
PL1896422T3 (pl) Inhibitory kinazy tyrozynowej
IL194491A0 (en) Thiazolyldihydroindazole derivatives as protein kinase inhibitors
EP1951252A4 (fr) Inhibiteurs des tyrosine kinases
EP1893194A4 (fr) Inhibiteurs de la proteine kinase a base d'indolinone amelioree
ZA200810573B (en) Substituted 3-cyanopyridines as protein kinase inhibitors
GB0516967D0 (en) Inhibitors
GB0621719D0 (en) Ikk- serine-threonine protein kinase inhibitors